PEPG: PepGen Inc. Stock

by  •  • Comments Off on PEPG: PepGen Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 49.08
Enterprise Value ($M) 5.45
Book Value ($M) 91.81
Book Value / Share 2.81
Price / Book 0.53
NCAV ($M) 65.46
NCAV / Share 2.00
Price / NCAV 0.75

Profitability (mra)
Return on Invested Capital (ROIC) -0.93
Return on Assets (ROA) -0.49
Return on Equity (ROE) -0.57

Liquidity (mrq)
Quick Ratio 4.95
Current Ratio 4.95

Balance Sheet (mrq) ($M)
Current Assets 101.05
Assets 127.39
Liabilities 35.59
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -97.74
Net Income -89.98
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -82.37
Cash from Investing -37.67
Cash from Financing 88.75

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-28 13G Point72 Asset Management, L.P. 5.70
02-14 13G/A Janus Henderson Group Plc 1.60 -77.65
02-14 13G Rtw Investments, Lp 9.80
02-07 13G Suvretta Capital Management, Llc 5.10 0.00
11-14 13G/A Viking Global Investors Lp 4.50 0.00
11-12 13G/A Qatar Investment Authority 3.82 0.00
2024-04-09 13G Oxford Science Enterprises plc 14.70

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2025-02-24 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 45,491 320,769 14.18
2025-05-08 176,351 604,876 29.15
2025-05-07 33,193 74,219 44.72
2025-05-06 42,897 120,362 35.64
2025-05-05 42,185 123,639 34.12

(click for more detail)

Similar Companies
PBYI – Puma Biotechnology, Inc. PCRX – Pacira BioSciences, Inc.
PCVX – Vaxcyte, Inc. PGEN – Precigen, Inc.
PHAT – Phathom Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io